Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Modafiendz is a non-peptide diphenylmethylsulfinylacetamide, specifically an N-methylated, bis(4-fluoro)-ring-substituted analog of modafinil. It is an unapproved research/designer chemical with no marketing authorization in any jurisdiction and no validated human dose. Its closest structural relatives, flmodafinil (CRL-40,940) and fladrafinil (CRL-40,941), are explicitly named as WADA-prohibited S6 stimulants on the 2026 list; Modafiendz itself is not explicitly named but may fall under WADA's generic “similar structure or effect” clause. No human pharmacokinetic, safety, or efficacy studies have been published.
Verified purity per dollar — the cheapest that's actually been tested
No prices found for Modafiendz.
Single-vial list prices by default for a fair head-to-head — switch to Multi-vial / bulk for pack pricing. Estimates only; verify at vendor before purchase. For research use only. Not medical advice.
Kimera Chems has the lowest single-vial Modafiendz price at $0.017/mg among 2 COA-verified vendors on Disclosed Labs. Bulk or multi-vial deals may be lower.
What is the price range for Modafiendz?
Research-grade Modafiendz is listed at $0.017/mg from 1 verified source on Disclosed Labs.
How are Modafiendz prices verified on Disclosed Labs?
Every listed vendor holds a Grade C or better trust score, computed independently from lab Certificates of Analysis — not from payments or sponsorships. Prices are scraped and fact-checked daily. Vendors cannot pay to improve their ranking.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Use the Full safety panel filter to require endotoxin, sterility, and heavy-metals testing on the current batch — not just HPLC purity.
No human data exists. No ClinicalTrials.gov record, no DrugBank entry, and no INN was found; NCATS Inxight Drugs classifies it only as “Other (designer drug),” racemic, with no approval year. Only two PubMed-indexed publications reference this compound, both analytical/forensic chemistry papers: one validated an LC-HRMS method to screen dietary supplements for modafinil analogs (adrafinil, not Modafiendz, was confirmed present in tested products), and one analyzed heat-induced thermal degradation during GC-MS (relevant to forensic identification). No preclinical pharmacology, toxicology, or efficacy studies in animals have been published.
This platform provides informational tools only, not medical advice.
Development and Validation of an Analytical Method to Identify and Quantitate Novel Modafinil Analogs in Products Marketed as Dietary Supplements
2025
Outsmarted by nootropics? An investigation into the thermal degradation of modafinil, modafinic acid, adrafinil, CRL-40,940 and CRL-40,941 in the GC injector
2017
SARs at the Monoamine Transporters for a Novel Series of Modafinil Analogues
Prices verified as of July 2026. Actual prices may vary. For research use only.
2010
Disclosed Labs